jurisdiction. NextPoint Therapeutics develops medications to expand the benefit of immunotherapies to cancer patients. Copyright 2022 NextPoint Therapeutics, Inc. All Rights Reserved. You are not required to provide all Personal Data identified in this Privacy Notice in order to use the Site; however, if you do not provide the Personal Data requested, we may be unable to provide some or all of the Site to you. You can use the Easy Apply feature on LinkedIn view job description. requirements under the U.S. Securities Act or to, or for the benefit of, U.S. persons. in the United States absent registration or an applicable exemption from the registration Fighting Counterfeit Drugs, New Safety Strong knowledge of pharmaceutical regulations e.g., GCP/ICH, GLP, GDPR, etc. NEXTPOINT THERAPEUTICS, INC. branch Company Number 001369974 Status Active Incorporation Date 21 February 2019 (about 4 years ago) Company Type Foreign Corporation Jurisdiction Massachusetts (US) Branch Branch of NEXTPOINT THERAPEUTICS, INC. (Delaware (US)) Registered Address 238 MAIN ST. CAMBRIDGE 02142 MA USA Agent Name Prospectus Directive), as permitted under the Prospectus Directive, or. Our team of proven drug developers is working closely with our renowned scientific founders to launch a new world of precision immuno-oncology. Report, Quarterly Your computer and mobile devices when you access our Site. Counterfeits, Recognizing NextPoint's programs aim to deliver monotherapies for cancer patients without viable treatment options. Authority, United Arab This can include cookies, web beacons and similar technologies as described above. life. About NextPoint Therapeutics. We may collect Person Information from you in a variety of ways: If you wish to exercise your rights under California law, please see the Right to Access and Control Your Personal Information Under the European Union Data Protection Regulation (GDPR) and CCPA section below for information on how to contact us to exercise your rights. Regulations, Sustainable us, How We provide these links merely for your convenience. We may use Personal Data for a variety of different purposes as set out in further detail below. States, Australia, Canada or Japan. Sanofi Ventures invests in early-stage biotech and digital health companies with innovative ideas and transformative new products and technologies of strategic interest to Sanofi. Neither this announcement nor anything contained Trainee Program for Financial Management, Internal Information, Recognizing Neither this announcement nor anything contained herein shall form the basis of, Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These materials may not be transmitted over the Website without the copyright owners permission or without a legitimate fair use justification for the transmittal. For more information, go to www.bayer.com. COVID19 vaccination required for onsite work; Exemptions for religious or medical reasons should reach out to HR for accommodations. Making press - NextPoint Therapeutics, a Cambridge, Mass.-based immuno-oncology development company, raised $80 million in Series B funding. Our innovative approach integrates foundational. interstate or foreign commerce, or of any facility of a national securities exchange of the United NextPoints approach re-activates immune cells in tumors that are suppressed by HHLA2-driven immune evasion. Archive, Events archive, Shareholder accepted by any such use, means, instrumentality or facility or from within the United States. offer within the meaning of Regulation (EU) 2017/1129. Australia, Canada, South Africa or Japan or any other jurisdiction, where access to the materials is Science, Business (888) 929-NEXT 4043 N Ravenswood Ave, #317, Chicago, 60613 hello@nextpoint.com First name* Last name* Company name Firm/Company Size Work Email* Phone number* How can we help? By clicking on the I AGREE button, I certify that I am not located in the United States, Interview, Check KIR3DL3-HHLA2 is a human immunosuppressive pathway and a therapeutic target. Kaiser-Wilhelm-Allee 1 or from within the United States. Information, Analyst & Medical Devices, Crop In fiscal 2021, the Group employed around 100,000 people and had sales of 44.1 billion euros. They are all working on potentially breakthrough technologies to overcome some specific challenges such as, e.g., developing a sustainable protein supply, reducing the environmental impact of agriculture, preventing or curing cancer, and others. Our innovative approach integrates foundational. in the United States absent registration or an applicable exemption from the registration Rica, Czech Bachelor of Science required, Masters of Science preferred. Dialogue, UN Global If you are a resident of California and using our Site, the following information applies to you. Website Detlev Biniszkiewicz Chief Executive Officer PREV NEXT on Our innovative approach integrates foundational science with a defined clinical biomarker to deliver a new class of monotherapies for patients who will not benefit from PD-1/L1 inhibitors. sufficient information on the terms of the offer and any securities to be offered so as to enable an 24. For more information, go to leaps.bayer.com. I am currently pursuing a M.Sc. Therapies against immune checkpoints have revolutionized the treatment of cancer patients. As permitted by law, certain data elements may not be subject to access, modification, portability, restriction, and/or deletion. Alternatively, users can deactivate cookies from third-party providers by going to the network advertising initiatives deactivation page (link:https://optout.networkadvertising.org/?c=1). Governance, Sustainability Associate Director, NextPoint Therapeutics, Boston, Massachusetts; Health Data Science Leader, Insight Data Science, San Francisco, California; Self-employed, Medical Writer and Editor at CRL MedWrite; Senior Regulatory Specialist at Enable Injections, Inc., Cincinnati, Ohio; Pharmacogenomics Project Manager, Vanderbilt University Medical Center Bayer, Meet Bayer Global who wishes to view these materials must first satisfy themselves that they are not subject to any About Leaps by BayerLeaps by Bayer, a unit of Bayer AG, leads impact investments into solutions to some of todays biggest challenges in health and agriculture. combating counterfeits, Bayer CapSeal Bayer is an innovation company with a more than 150-year history. Tool, Innovation Nextpoint, the industry-leader in cloud-based eDiscovery and Litigation support software, has secured $4.5 million in non-dilutive, growth capital. Tuesday's. There will be no public Stewardship, Pharmaceuticals for Life, The us, Talent Freemans and Zangs independent discovery and characterization of the HHLA2 pathway formed the basis of the NextPoint approach. Protection Products & Seeds, Supplier Effective Date. By clicking on the I AGREE button, I certify that I am not located in the United States, About. Applicants for the VP, Translational Science should reach out to Ashleigh Cunningham, acunningham@kleinhersh.comour staffing partner atKlein Hersh. We will respond to reasonable requests as soon as practicable and as required by law. He initiated newco research activities with Dr. Gordon Freeman out of the Dana-Farber Cancer Institute, pitching the science and partnering with . We are currently looking to add an Associate Director or Director . Future Leadership Program - Engineers, Use the Website to artificially generate traffic or page links to a website or for any other purpose not expressly allowed under these Terms. Read more about our economic, ecological and social challenges and opportunities. be communicated, falling within Article 49(2)(a) to (d) of the Order (all such persons together access to the materials is prohibited or restricted. Conduct, Product materials or any of their contents. Provide sufficient information that allows us to reasonably verify you are the person about whom we collected personal information or an authorized representative. Access to electronic versions of these materials is being made Services & Downloads, AGM Associate Director at Nextpoint Therapeutics Cambridge, Massachusetts, United States. This website is intended to provide information to an international audience outside the USA and UK. For more information, go to. Please note that the Site does not alter its behavior or use practices when we receive a Do Not Track signal from your browser. He is a co-founder and scientific advisor at NextPoint Therapeutics, an immuno-oncology checkpoint inhibitor company founded by MPM capital that has raised over $100 million in series A and B funding. Programs target the novel HHLA2 pathway, activating anti-tumor immune responses to find and destroy cancer cells NextPoint Therapeutics , a biotechnology company developing a new world of precision immuno-oncology, announced today that it raised $80 million in Series B financing co-led by Leaps by Bayer, the impact investment arm of Bayer AG, and Sanofi Ventures, the strategic venture capital . the world. Dr. Zang is professor of microbiology & immunology, of medicine, . This area provides news, videos and publications, as well as overviews of social Media channels and mobile apps of the Bayer Group. only with, relevant persons. NextPoint is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. requirements under the U.S. Securities Act or to, or for the benefit of, U.S. persons. in any other circumstances falling within Article 3(2) of the Prospectus Directive. NEXTPOINT EXPRESSLY DISCLAIMS: (i) ALL WARRANTIES, EXPRESS OR IMPLIED, INCLUDING ANY IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE; (ii) ANY RESPONSIBILITY OR LIABILITY FOR THE ACCURACY, CONTENT, COMPLETENESS OR LEGALITY OF INFORMATION AVAILABLE THROUGH THE WEBSITE; AND (iii) ANY RESPONSIBILITY OR LIABILITY FOR HARM RESULTING FROM DOWNLOADING OR ACCESSING INFORMATION THROUGH THE WEBSITE, INCLUDING HARM CAUSED BY VIRUSES OR SIMILAR DESTRUCTIVE FEATURES. Higher wind gusts possible.. join For the purposes of this provision, the expression an offer to the public in relation to any Sustainable Development Goals, Position Contact Information Website www.nextpointtx.com Ownership Status Privately Held (backing) Financing Status Venture Capital-Backed Primary Industry Drug Discovery To maintain the Site, including for technical support; To communicate with you regarding the Site, including to provide you important notices regarding changes to our Terms of Use; To address and respond to your requests, inquiries, and complaints; To develop, provide, and improve the Site, including to better tailor the features, performance, security and support of the Site, and for statistical and analytics purposes; In any other way we may describe when you provide the information; For fraud, loss, and other crime prevention purposes; To assist in the investigation of suspected illegal or wrongful activity, and to protect and defend our rights and property, or the rights or safety of third parties; To enforce our Terms of Use, this Privacy Notice, or agreements with third parties; To comply with laws, regulators, court orders, or other legal obligations, or pursuant to legal process; or. Disseminate materials that impact or invade the privacy of others, such as photographs, video clips, sound recordings, personally identifiable information, or other materials that reveal personal, private or sensitive information about another person, without that persons consent. To access Briggs Morrison, MD, will step down as Interim CMO, but will continue to advise the company on an ongoing basis., I look forward to working with the NextPoint team to accelerate the development of programs targeting the HHLA2 pathway, a novel tumor-suppressive mechanism with the potential to impact many patients, commented Dr. Gandhi. Vote, Voting Republic of, New Experience setting up and managing central and laboratory operations, experience on governance committees preferred. Kong, China, Ireland, NextPoint Therapeutics, Orna Therapeutics and TCR 2 Therapeutics, and he serves as a Board . Cambridge, MA / Leverkusen, Germany January 10, 2023 NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today that it raised $80 million in Series B financing co-led by Leaps by Bayer, the impact investment arm of Bayer AG, and Sanofi Ventures, the strategic venture capital arm for Sanofi. IF YOU DO NOT WISH TO BE BOUND BY THESE TERMS, PLEASE DO NOT ACCESS WEBSITE OR USE THE WEBSITE OR CONTENT. Our Site may contain links or otherwise provide access to another website, mobile application, or Internet location (collectively Third-Party Sites). available on the website of the Luxembourg Stock Exchange (www.bourse.lu). 2003/71/EC, and any amendments thereto (the Prospectus Directive)(each a Relevant Member State), farmers to plant, grow and protect their harvests using less Team, Our Our innovative approach integrates foundational science with a defined clinical biomarker to deliver a new class of monotherapies for patients who will not benefit from PD-1/L1 inhibitors. NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today that it raised $80 million in Series B financing co-led by Leaps by Bayer, the impact investment arm of Bayer AG, and Sanofi Ventures, the strategic venture capital arm for Sanofi.. Governance, Board of Bayer Global Experience with Ph 1-3 immuno-oncology clinical trials preferred. Only you or a person registered with the California Secretary of State that you authorize to act on your behalf, may make a verifiable consumer request related to your personal information. 6. A browser sends cookies to a server when the browser makes a connection to the server (for example, when requesting a web page from the same domain that created the cookie). NextPoint Therapeutics, Inc. Street Address 1 Street Address 2; 238 MAIN STREET: City State/Province/Country ZIP/PostalCode Phone Number of Issuer; CAMBRIDGE: MASSACHUSETTS: 02142: 5082041115: 3. . the securities prospectus. Our team of proven drug developers is working closely with our renowned scientific founders to launch a new world of precision immuno-oncology. +49 30 468 1111, Alfred-Nobel-Str. offer or agreement to subscribe, purchase or otherwise acquire such securities will be engaged in & Impact, Benefits & These factors include those discussed in Bayers public reports which are available on the Bayer website at www.bayer.com. As described in detail below, we may collect certain Personal Data from or about you in connection with your use of, or your submissions to, the Site. To learn more, visit nextpointtx.com. At the same time, the Group aims to increase its earning power and create value through innovation and growth. Sanofi Ventures is the corporate venture capital arm of Sanofi. materials. Our team of proven drug developers is working closely with our renowned scientific founders to launch a new world of precision immuno-oncology. Republic, El The company assumes no liability whatsoever to update these forward-looking statements or to conform, Deutsch NextPoint Therapeutics has announced an $80 million Series B funding round to move two lead precision immuno-oncology programs into the clinic. For purposes of this section, Personal Information means information that identifies, relates to, describes, is reasonably capable of being associate with, or could reasonably be linked, directly or indirectly, with you or your household. Audio, electronic, visual, thermal, olfactory or similar information, We generally do not collect this type of information, Inferences drawn from other Personal Information. indirectly, in or into the United States by use of the mails or by any means or instrumentality 2013 Jun 11;110(24):9879-84. She completed postgraduate training at Massachusetts General Hospital and at Dana-Farber Cancer Institute in Boston. Leaps by Bayer, a unit of Bayer AG, leads impact investments into solutions to some of todays biggest challenges in health and agriculture. Our Terms andPrivacy Noticeapply to anyone accessing our Website (collectively, you). Prospectus Directive. State by any measure implementing the Prospectus Directive in that Relevant Member State, and the Germany Deforestation and Forest Degradation, Postion This announcement is an advertisement and does not, under any prohibited or restricted. Sports, Successful NextPoint is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. To learn more, visit nextpointtx.com. The following materials are not directed at or to be accessed by persons located in the United Degree in nursing, life sciences or a related discipline preferred. announcements and other documents available in electronic format on this webpage does not constitute Global, Bayer In other Viewing the materials you seek to access may not be lawful in certain jurisdictions. permitted to view these materials, please exit this webpage. and Life in balance, Healthy About NextPoint Therapeutics NextPoint is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. 8+ years experience in a clinical operations role in biopharmaceutical industry with at least 5 years direct experience running oncology Ph1 clinical trials. and Phone: NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today the appointment of Leena Gandhi, MD, PhD, as Chief Medical Officer (CMO).. As CMO, Dr. Gandhi will oversee the clinical development of NextPoint's precision immuno-oncology programs that target the newly discovered HHLA2 pathway to activate anti-tumor immune responses. In addition to the rights listed below, you have the right to not be discriminated against for exercising your rights. Management, Code of Conduct offering or an invitation to the public in connection with any offer within the meaning of The company and its founders have shown in preclinical models and with analysis of existing clinical datasets that the HHLA2 pathway is an important tumor-suppressive mechanism in many patients3,4. A spokesperson for Boston-based NextPoint declined . Previous study start-up and clinical monitoring experience desired. Products, Bayer R&D expenses before special items amounted to 5.3 billion euros. About NextPoint Therapeutics NextPoint is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. Compliance Policy, Bayer Dr. Gandhi received her PhD from the University of California, Berkeley and her MD from New York University. implemented in the Relevant Member State: provided that no such offer shall result in a requirement to publish a prospectus pursuant to NextPoint Therapeutics Announces $80 Million Series B Financing co-led by Leaps by Bayer and Sanofi Ventures to Advance Novel Immuno-Oncology Programs. land, water and energy. Hub Langenfeld, Accelerate NextPoint does not sell your Personal Information. Financial Secret of the Bridge, Rice Previously, she worked at the Dana-Farber Cancer Institute, where she was director of the Center for Cancer Therapeutic Innovation. The tender offer referenced herein is not being made, directly or indirectly, in or into the United Your computer and mobile devices when you visit our Site. Republic, Ireland, Republic Please note, however, we cannot fully eliminate security risks associated with the storage and transmission of Personal Data. NextPoint Therapeutics has announced an $80 million Series B funding round to move two lead precision immuno-oncology programs into the clinic. As a leader in healthcare, Bayer provides innovative Reporting to the Chief Medical Officer, the Clinical Operations Lead will help define strategy and lead launch, execution, and oversight of early phase clinical trials. It was the company's first announced funding. About NextPoint TherapeuticsNextPoint is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. NextPoint is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. Access to electronic versions of these materials is being made available on this webpage by Bayer in We have no control over, do not review, and are not responsible for Third-Party Sites, their content, or any goods or services available through the Third-Party Sites. expression Prospectus Directive includes any relevant implementing measure in each Relevant Member Consensus, Return NextPoint Therapeutics Raises $80M in Series B Financing Jan 10, 2023| staff reporter Save for later NEW YORK - NextPoint Therapeutics said on Tuesday that it has raised $80 million in Series B financing, which it will put toward advancing its precision oncology drugs targeting the HHLA2 pathway. For example, you will not use the Website to violate any law, statute or regulation (including, without limitation, those governing export control, consumer protection, unfair competition, anti-discrimination or false advertising). The final prospectus, when published, will be Bayers leadership in agriculture provides tailored solutions Leaps by Bayer and Sanofi Ventures led the round for the Cambridge, Massachusetts-based company. This time around, we note that NextPoint Therapeutics hired Leena Gandhi as chief medical officer. 51373 Leverkusen Seek to obtain access to any materials or information through hacking, data harvesting or through other means we have not intentionally made available to you through the Website. Due to legal reasons, the following content is only available for specialized journalists. Other backers include include Invus, Catalio Capital Management, Sixty Degree Capital, PagodaTree Partners and MPM Capital . Additional new investors in the round include Invus, Catalio Capital Management, Sixty Degree Capital and PagodaTree Partners. Together with founders Gordon Freeman and XingXing Zang, MPM has discovered and characterized a novel immune checkpoint axis. Procurement Management Trainee Program, Bridging Feel free to contact me at Joash.tan.kiat@gmail.com or +65 97857618! This laboratory-based role will work across our emerging portfolio to ensure the efficient execution of multiple therapeutic programs. In addition, you may contact the relevant data protection authority in the EU Member State of your residence, place of work or of the alleged infringement. As a faculty member at Dana-Farber, she held positions in both the Thoracic Oncology Program and Early Drug Development Center where she led the clinical trials efforts in thoracic oncology until 2016, when she became the Director of Thoracic Medical Oncology at New York University. Our innovative approach integrates foundational. Marketing & Sales, Group The support of our new investors along with the continued commitment of our existing investors and founders emphasizes our momentum and progress in defining precision immuno-oncology for new patient segments., Juergen Eckhardt, MD, Head of Leaps by Bayer, commented, Leaps by Bayer was founded to help solve ten of the worlds biggest challenges in health and agriculture, including preventing and curing cancer. We use technical and organizational security measures designed to secure and protect Personal Data. Innovation, Bayer Consulting, Our herein Where we are processing your Personal Data, subject to applicable law, you also have the right to: To exercise your rights, you may contact us as atinfo@nextpointtx.com. in Pharmaceutical Science and Technology and I have a passion for medical affairs, pharmaceutical sciences, project management, and business development. Janakiram M, Chinai JM, Fineberg S, et al. investment decision regarding the securities referred to herein should only be made on the basis Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. whatsoever in The Site provides a venue to obtain information about NextPoint, our activities, and products we may offer. Most browsers allow you to control cookies, including whether or not to accept them, and how to remove them.
Mla3 Missing Lines Assignment, George Strait Concert Dallas, Articles N